Initiatives from El Salvador, Mexico, and the United States of America recognized with World No Tobacco Day Awards

Events
Jun.13.2022

Washington D.C. May 27 2022 (PAHO) – A tobacco control advocate in El Salvador, Violeta de Palomo, the President of Mexico, Andres Manuel Lopez Obrador, and a researcher and academic from the United States of America, Thomas Novotny, received the 2022 World No Tobacco Day (WNTD) Awards.

The winners, selected by the World Health Organization (WHO) from global nominations in response to a public call, have been recognized for their efforts to ensure progress towards tobacco control in their countries.

Initiatives from El Salvador, Mexico, and the United States of America recognized with World No Tobacco Day Awards

In El Salvador, Violeta de Palomo won the award for her work with Fundahabla, an organization she founded in 2014 to provide health care, psychological support, speech therapy, and rehabilitation for people with laryngeal cancer. As a leader of the anti-tobacco movement in El Salvador, Violeta also coordinates the @sumatecontraeltabaco initiative to ensure 100% smoke-free public spaces, support for smoking cessation, and advocacy for increasing taxes on tobacco products.

 

In Mexico, President Andres Manuel Lopez Obrador received the WHO Director-General’s Special Recognition Award for his leadership and unwavering support for strengthening tobacco control measures in his country. His efforts led to the unanimous approval of the reform of the General Law for Tobacco Control in 2021, which has resulted in a complete ban on tobacco advertising, promotion and sponsorship, as well as the creation of smoke-free environments throughout the country. Over the course of the past year, Lopez Obrador has reaffirmed the importance of tobacco control, ensuring that the right to health of all Mexicans supersedes the interests of the tobacco industry.

 

In the United States, Thomas Novotny, Professor Emeritus at San Diego State University School of Public Health, won the award in recognition of his research and advocacy around the environmental impact of tobacco, particularly regarding post-consumer waste such as filters. Novotny is a founding member of the Cigarette Butt Pollution Project (CBPP), an organization that campaigns against the environmental impact of tobacco products, particularly cigarette butts.

World No Tobacco Day was created by WHO Member States in 1987 and is commemorated each year on 31 May. The aim of the day is to raise awareness of the harmful effects of tobacco use and second-hand smoke exposure.

 

The theme of World Not Tobacco Day 2022 is “Poisoning our planet”. Tobacco kills over 8 million people every year and destroys the environment, further harming human health through its cultivation, production, distribution, consumption, and through post-consumer waste.

 

Also read:

Juul Gets Temporary Reprieve to Keep Selling Its E-Cigarettes

Will the new Juul ban help Colorado’s high teen vape use?

Multi-State Coalition Urges F1 to End Nicotine Sponsorships, Citing Zyn and Velo
Multi-State Coalition Urges F1 to End Nicotine Sponsorships, Citing Zyn and Velo
Hawaii Attorney General Anne Lopez is co-leading a coalition of 19 states and jurisdictions urging the Fédération Internationale de l’Automobile (FIA) and Formula 1 to end sponsorships involving tobacco and nicotine products, including nicotine pouch brands such as Zyn and Velo.
News
Jun.09
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
Thailand’s Bangkok Port Customs Reports E-Cigarette and Nitrous Oxide Seizure Worth More Than THB 27 Million
Thailand’s Bangkok Port Customs Reports E-Cigarette and Nitrous Oxide Seizure Worth More Than THB 27 Million
Bangkok Port Customs on April 28 announced the seizure of 52,000 complete e-cigarettes, 100 gallons of e-liquid and 126,226 canisters of nitrous oxide, with total economic damage exceeding THB 27 million, or about USD 831,178 based on an April 28 USD/THB rate of 32.484. The e-cigarette and e-liquid shipment was valued at THB 5.56 million, or about USD 171,161, while the nitrous oxide shipment was valued at THB 21.27 million, or about USD 654,784.
Apr.29 by 2FIRSTS.ai
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
Special Report|Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?
Special Report|Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?
Haypp Group reported a 40% year-on-year increase in nicotine pouch volumes in the first quarter of 2026, with U.S. and U.K. volumes rising 123% and 102%, respectively. Haypp says around 97% of its consumer traffic is organic and that its Media & Insights business provides brand owners with on-site visibility, trial activation and consumer intelligence. For international tobacco companies, Haypp may be both a growth partner for modern oral products and a new source of channel leverage.
Special Report
May.22
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18